Caucasian girl smiling while looking at her cell phone during her morning cup of cappachino while she checks her mails on an electronic tablet in her favourite coffee shop with bright light.

NASH Ambition Study

Ages

18 - 75

Location

Columbus, OH

Compensation

Up to $700*
Caucasian girl smiling while looking at her cell phone during her morning cup of cappachino while she checks her mails on an electronic tablet in her favourite coffee shop with bright light.

NASH Trials in Columbus

Aventiv Research is currently participating in the NASH Ambition study at our Columbus, Ohio location. NASH (Non-Alcoholic SteatoHepatitis) is the form of liver disease that is triggered by what has come to be known as the “Western diet”, characterized especially by high-fat, high-sugar, and processed foods. Among the effects of a prolonged Western diet is fat accumulation in liver cells (steatosis) which is described as Non-Alcoholic Fatty Liver Disease (NAFLD) and can predispose cells to injury.

People who develop NASH often have additional predisposing conditions such as diabetes and hypertension, but the exact biochemical events that trigger and maintain the progression are not well known. Many people in the early stages of disease do not have significant symptoms and therefore do not know that they have it.  Advances in drug therapy are key to treating this disease at its early stages and preventing further liver damage.

Enroll Now

NASH Ambition Study

The primary objective of the NASH Ambition clinical study is to evaluate the safety and tolerability of an investigational drug in presumed nonalcoholic steatohepatitis (NASH) fibrosis stage 2
(F2)/fibrosis stage 3 (F3) patients compared to placebo. You may be eligible to participate if you:

  • Are 18 – 75 years old
  • Have been diagnosed of NASH
  • Cannot have known non-NASH liver diseases including:
    • Autoimmune diseases
    • Alcoholic liver disease
    • HIV
    • Active Hepatitis B or C

We now offer individuals with known risk factors of Non-Alcoholic Fatty Liver Disease (NAFLD) a free Fibroscan screening.

Ready to Volunteer?

Volunteer today to see if you qualify for our NASH Ambition clinical research study. *Qualified volunteers may be compensated for time and travel.